While modern medicine can treat some diseases once thought incurable, increasingly complex chemical compounds in modern pharmacology often cause unpredictable side effects that can lead to secondary diseases.
Traditional (or what is sometimes called “alternative”) pharmacopoeia offers solutions which can be less detrimental. However, outside the context of the broader traditional natural healing methodology, these medicinal compounds are often less effective and can still cause harmful side effects.
One possible alternative to the problems mentioned above is the use of modern and innovative electrotherapeutic medical devices. When appropriately implemented, various types of electrical currents and magnetic, electric, and electromagnetic fields allow direct modification of cellular metabolism in both prokaryotic and eukaryotic cells. Additionally, varying absorption rates across tissues are inherent to both modern and traditional pharmacopoeia-based therapies. However, tissue-penetrating EM fields do not entirely overcome these problems. Admittedly, it is quite possible to cause cellular damage if one is not observant of some basic rules. However, when implemented correctly, this approach can indeed open a new avenue for medical therapies.
Most conventional electrotherapy devices used in modern medicine, often in physical rehabilitation, are based on galvanic current therapy, TENS stimulation, or a low-strength oscillating magnetic field. Such devices are used almost exclusively for pain treatment, muscular stimulation, and bone-healing facilitation. The overall effectiveness of these electrotherapy devices is limited because they primarily treat symptoms. They cannot address the underlying medical conditions that initially caused the symptoms.
Furthermore, they cannot directly induce significant bioactive effects, such as modifying cellular metabolism and rejuvenation, eradicating pathogens, inducing programmed apoptosis of neoplastic cells, or directly modifying the body’s pH.
On the other hand, many older electrotherapeutic technologies can achieve some of the aforementioned bioactive effects but are also more specialised in function.
Work on Innovative Electrotherapy Devices
We started experimenting back in 2000. It took nearly two and a half years to produce the first device capable of generating an appropriate high-frequency signal, modulating it, and mixing it, enabling experimentation with much more complex waveforms. Experimenting with pulsed magnetic field (PMF) devices also started to determine if any common denominators exist, making them more (or less) efficient for “in vivo” medical treatments. It took another five years to “connect the dots” and realise that common factors were indeed responsible for the induced bioactive effects observed across different technologies.
At that point, we started considering the best way to practically apply the knowledge we had gained to develop new types of electromedical devices capable of treating some medical conditions and diseases that are otherwise untreatable with any other publicly known technology.
Initially, we planned to design a single device that would embody all the underlying principles we observed over years of research. However, it soon became clear that developing such an electrotherapeutic device would be practically impossible with the limited funds we had at the time. Instead, we focused on developing separate, more specialised electrotherapy devices that could address some of the problems inherent in modern pharmacological and medical treatments.
Cell Metabolism Rejuvenation
At first, we focused on developing an electromedical device capable of producing specific, complex signals that stimulate cell metabolism and rejuvenate cells by modifying electrochemical reactions within and around living cells. The goal was primarily to stimulate the ionic exchange processes of the Na+/K+ pump (ATPase), which would, in turn, increase cellular energy exchange and transmembrane potential.
We found that it is possible to directly increase the transmembrane potential by applying specifically synthesised electrical signals, thereby affecting cellular ionic exchange processes. To achieve that, we decided to abandon somewhat complex and expensive technologies based on plasma antenna radiators (for example, “Rife” technologies) that required more complex electrical design and relatively expensive parts. Finally, we decided to develop the device by applying an electrical signal via direct electrode contact with the body. Although the beneficial effects on the body were immediate and undeniable, we spent most of our development time designing the electronic circuitry to be safe for clinical use while retaining those benefits.
In 2008, we made the first entirely functional prototype for experimental purposes. At that point, the device was tested at a small clinic in the Netherlands, primarily for pain treatment. Based on the feedback we received, we designed two additional generations of the cell metabolism rejuvenation device, making it even more versatile.
Interestingly, it also became evident that this type of electromedical device appears to have the most beneficial side effects. With proper output-signal settings and appropriate electronic circuitry, it appears possible to induce programmed apoptosis in cells with low transmembrane potential (e.g., neoplastic cells) while simultaneously stimulating ionic exchange processes in healthier cells (electrically speaking). Thus, it normalises their transmembrane potential and metabolic processes.
Although the device was designed to increase transmembrane cell potential directly, it was still a bit of a surprise to find that specific electrical signals can selectively induce cellular “suicide” in neoplastic (low transmembrane potential) cells, without harming healthy cells.
The effects of the selective killing of various types of prokaryotes with no apparent damage to the eukaryotic cells were no surprise to me, but what did surprise me was that pretty much similar effects were observed with certain viral infections. For example, we observed that the viral load in the blood of a cat with FIV (a virus somewhat similar to HIV) dropped rapidly and significantly when the cat was treated with electrical signals generated by the device.
Although this electrotherapeutic method appears promising for treating various medical conditions and diseases, it is not a panacea. It certainly has limitations, and in some diseases, it shows minimal effectiveness because of differences in the underlying disease mechanisms.
Direct Modification of Body PH and Neutralisation of Excessive Levels of Free Radicals
Alongside developing the cell metabolism rejuvenation device, we have also been developing a different type of electrotherapy device that can quickly and efficiently modify and regulate body pH directly, as well as neutralise free radicals “in vivo”.
Because of our previous involvement in a commercial project on zeolite processing and enhancement for medicinal purposes, we understood the importance of using strong antioxidants to modify body pH (alkalisation in this case) and neutralise excessive levels of free radicals. They proved to be significant contributors to treating some neoplastic and autoimmune diseases. At that point, we had already developed a prototype for industrial processing and electrochemical enhancement of zeolites and similar micronised minerals, which measurably increases their electrochemical reactivity several times. Although the resulting enhanced mineral products exhibit the highest physically possible antioxidative properties, several times higher than those of commonly used antioxidants and conventionally micronised and activated zeolite, we were still not satisfied with the achieved rate of neutralisation of excessive free radical levels.
We knew that in most severe cases of neoplastic and autoimmune diseases, rapid and efficient alkalisation of the affected tissues and the entire body, as well as the reduction of excessive free radical levels, are of paramount importance.
Although we found somewhat interesting references to historical, as well as somewhat more modern devices trying to achieve such effects “in vitro” in limited laboratory conditions, our initial experiments indicated that things are somewhat more complex if one is to achieve similar effects “in vivo” with complex multicellular organisms like humans and animals.
Initial “in vitro” experiments showed that the concept we had in mind was viable. However, it required further experimentation to determine the most efficient way to reliably and safely achieve the same results “in vivo”. For example, we found that when the experimental device’s oscillation amplitude was too low, the rate of free radical neutralisation was virtually negligible.
On the other hand, when the oscillatory output amplitude was too high, it sometimes caused unpleasant side effects from nervous system over-excitation, resulting in mild spatial disorientation and vertigo.
Finally, we overcame those initial obstacles in late 2008 and early 2009, which led to the successful development of the first, rather unsophisticated prototype. Even in those early stages, the results were reliable and could be reproduced and verified by laboratory tests in any medical biochemistry laboratory. With additional funding at that stage, the device evolved into two subsequent generations based on data gathered during testing at a small clinic in the Netherlands.
Once perfected, this device proved extremely efficient at very fast, controlled alkalisation of the entire organism and at reducing excessive levels of free radicals. This fast, non-invasive method of neutralising free radicals shows excellent potential for treating all medical conditions caused or indicated by elevated free radical levels in and around affected tissues.
Device for direct modification of body pH and neutralisation of excessive levels of free radicals
Aside from the obvious applications as supplemental therapy for various neoplastic and autoimmune diseases, one of the more exciting fields of use is anti-ageing treatments and reducing cellular damage caused by exposure to ionising radiation. Sources of such ionising radiation include X-ray, CT, and PET scans, which directly produce excessive levels of free radicals in the organism.
The human and animal population increasingly absorbs radioactive “hot particles” released by nuclear accidents. Each of those embedded radioactive “hot” particles invariably causes continuously increased production of free radicals, which often leads to the development of various degenerative and neoplastic diseases (for example, thyroid cancer). Perhaps an even more interesting application of this technology is to reduce the detrimental long-term effects of accumulated radioactive “hot” particles in the organism.
Current Research and Development of New Types of Electrotherapy Devices
We are currently working on entirely new technologies based on the knowledge and experience gained from our work and experiments with previously described devices. Additionally, we have had the opportunity to design, produce, and conduct experiments with historical replicas of the Lakhovsky Multiple Wave Oscillator and Rife Beam Ray.
It appears that some aspects of these technologies share common denominators that could be used to design and produce even more effective and capable electrotherapeutic devices. Plasma antenna radiator elements are of particular interest, in this case, because they can modify their radiation properties without physically changing their components. Such new technologies should be capable of inducing additional beneficial bioactive effects, some of which are virtually impossible to achieve even with the latest developmental generations of the current electromedical devices.